


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:51:14Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407214" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407214</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>eid</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">782</journal-id><journal-id journal-id-type="pmc-domain">eid</journal-id><journal-id journal-id-type="publisher-id">EID</journal-id><journal-title-group><journal-title>Emerging Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control and Prevention</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407214</article-id><article-id pub-id-type="pmcid-ver">PMC12407214.1</article-id><article-id pub-id-type="pmcaid">12407214</article-id><article-id pub-id-type="pmcaiid">12407214</article-id><article-id pub-id-type="pmid">40866958</article-id><article-id pub-id-type="doi">10.3201/eid3109.250479</article-id><article-id pub-id-type="publisher-id">25-0479</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research</subject></subj-group><subj-group subj-group-type="TOC-title"><subject>Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda</subject></subj-group></article-categories><title-group><article-title>Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda</article-title><alt-title alt-title-type="running-head">Rickettsioses as Cause of Febrile Illness, Uganda</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Blair</surname><given-names initials="PW">Paul W.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alharthi</surname><given-names initials="S">Sultanah</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Londo&#241;o</surname><given-names initials="AF">Andr&#233;s F.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wailagala</surname><given-names initials="A">Abdullah</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Manabe</surname><given-names initials="YC">Yukari C.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dumler</surname><given-names initials="JS">J. Stephen</given-names></name></contrib><contrib contrib-type="author"><collab>the Acute Febrile Illness and Sepsis in Uganda Study Teams<xref rid="FN1" ref-type="fn"><sup>1</sup></xref></collab></contrib><aff>Vanderbilt University Medical Center, Nashville, Tennessee, USA (P.W. Blair, S. Alharthi); Uniformed Services University, Bethesda, Maryland, USA (A.F. Londo&#241;o, J.S. Dumler); Makerere University, Kampala, Uganda (A. Wailagala); Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (Y.C. Manabe)</aff></contrib-group><author-notes><corresp id="cor1">Address for correspondence: Paul W. Blair, Vanderbilt University Medical Center, Division of Infectious Diseases, 1161 21st Avenue S, A-2200 Medical Center N, Nashville, TN 37232, USA; email: <email xlink:href="paul.blair@vumc.org">paul.blair@vumc.org</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>31</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496169</issue-id><fpage>1708</fpage><lpage>1717</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="25-0479.pdf"/><abstract><p>The complexity of rickettsial serodiagnostics during acute illness has limited clinical characterization in Africa. We used archived samples from sepsis (n = 259) and acute febrile illness (n = 70) cohorts in Uganda to identify spotted fever and typhus group rickettsiae by using immunofluorescence assay and clinically validated rRNA reverse transcription PCR (RT-PCR). Among 329 participants, 10.0% had rickettsial infections (n = 33; n = 20 identified with immunofluorescence assay and n = 13 by RT-PCR). Serum rRNA RT-PCR was 75.0% (95% CI 42.8&#8211;94.5%) sensitive and 91.2% (95% CI 85.8&#8211;95.1%) specific. Thrombocytopenia was more common among patients with rickettsial infections than with other nonmalarial infections (adjusted odds ratio 3.7; p = 0.003). No participants were on a tetracycline antimicrobial drug at admission. rRNA RT-PCR is a promising diagnostic strategy for identifying acute rickettsial infections. Doxycycline should be included in empiric antimicrobial drug regimens for nonmalarial febrile illness in this region.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Rickettsial infections</kwd><kwd>rickettsioses</kwd><kwd>bacteria</kwd><kwd>vector-borne infections</kwd><kwd>bacterial infections</kwd><kwd>sepsis</kwd><kwd>epidemiology</kwd><kwd>tick-borne</kwd><kwd>molecular diagnostic techniques</kwd><kwd>spotted fever group</kwd><kwd>typhus group rickettsia</kwd><kwd>sub-Saharan Africa</kwd><kwd>Uganda</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Rickettsial infections are challenging to clinically distinguish from other causes of febrile illness. Clinical, operational, and technical factors increase the difficulty of identifying rickettsioses in sub-Saharan Africa (<xref rid="R1" ref-type="bibr"><italic toggle="yes">1</italic></xref>). Rickettsial infections in sub-Saharan Africa are of international importance; among returning travelers from the region, rickettsioses are common causes of nonmalarial fever (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>&#8211;<xref rid="R5" ref-type="bibr"><italic toggle="yes">5</italic></xref>). Many patients do not have an obvious eschar (<xref rid="R5" ref-type="bibr"><italic toggle="yes">5</italic></xref>&#8211;<xref rid="R7" ref-type="bibr"><italic toggle="yes">7</italic></xref>), and clinical signs and symptoms are not well-characterized among those hospitalized in the region (<xref rid="R5" ref-type="bibr"><italic toggle="yes">5</italic></xref>,<xref rid="R8" ref-type="bibr"><italic toggle="yes">8</italic></xref>). Characteristic laboratory abnormalities of thrombocytopenia, leukopenia, and elevated transaminase activities are commonly observed clinical manifestations of the most prevalent tropical infections, including malaria, typhoid fever, arboviruses, or generalized sepsis (<xref rid="R9" ref-type="bibr"><italic toggle="yes">9</italic></xref>).</p><p>Clinicians do not have reliable diagnostics for acute rickettsioses (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>,<xref rid="R11" ref-type="bibr"><italic toggle="yes">11</italic></xref>). Empiric antimicrobial drug regimens rarely include antimicrobial drugs active against rickettsioses (e.g., tetracyclines) (<xref rid="R11" ref-type="bibr"><italic toggle="yes">11</italic></xref>&#8211;<xref rid="R13" ref-type="bibr"><italic toggle="yes">13</italic></xref>). Diagnostics are generally limited to acute- and convalescent-phase serology despite flaws in performance, sparse point-of-care availability, and almost absent acute care clinical utility (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>). Because of the low organism concentration within the bloodstream in acute infection, serum or whole blood PCR is generally insensitive at 18% (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>). rRNA, on the other hand, is highly abundant, conserved, and stable. Targeting rRNA with reverse transcription PCR (RT-PCR) is an approach that has been used to optimize analytical sensitivity in PCRs for rickettsial (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>) and other low bacterial burden infections (<xref rid="R15" ref-type="bibr"><italic toggle="yes">15</italic></xref>). Evaluations using archived samples from patients with rickettsioses and nonrickettsial diseases demonstrate real promise for improved detection sensitivity of rickettsial infections but have yet to be evaluated in samples from prospectively identified acute febrile illnesses in a comprehensive clinical study (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>,<xref rid="R16" ref-type="bibr"><italic toggle="yes">16</italic></xref>). To confirm the improved sensitivity of this approach, we developed and evaluated new primers targeting rRNA. We describe the performance of an rRNA-targeting RT-PCR to detect spotted fever group (SFG) rickettsiae and typhus group (TG) rickettsiae, compared with acute- and convalescent-phase immunofluorescence assays (IFA), among acute febrile hospitalized participants in 3 hospitals in rural Uganda. We used the results from those identified rickettsial infections to describe the features of hospitalized rickettsial infections and address a clinical epidemiology knowledge gap in this region.</p><sec sec-type="materials|methods"><title>Materials and Methods</title><p>According to internal review board&#8211;approved parent cohort protocols, participants were enrolled upon hospitalization. We collected demographic, symptom, examination finding, and laboratory data on standardized forms during hospitalization and at 1 month after enrollment (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref>) (<xref rid="R13" ref-type="bibr"><italic toggle="yes">13</italic></xref>,<xref rid="R17" ref-type="bibr"><italic toggle="yes">17</italic></xref>; P.W. Blair et al., unpub. data, <ext-link xlink:href="https://www.medrxiv.org/content/10.1101/2023.09.14.23295526v1" ext-link-type="uri">https://www.medrxiv.org/content/10.1101/2023.09.14.23295526v1</ext-link>). We collected acute blood samples at enrollment and convalescent samples at 1 month. We determined survival during in-person visits or telephone calls during a 1&#8211;3-month period after hospitalization in the acute febrile illness (AFI) cohort and a 12-month period in the sepsis cohort.</p><p>We used acute-phase serology from archived samples collected at parent study enrollment to determine seroprevalence in the sepsis (n = 311) and AFI (n = 122) cohorts. We conducted IgG IFA by using commercial slides (spotted fever group rickettsia, <italic toggle="yes">Rickettsia conorii</italic> Malish 7 strain; typhus group rickettsia, <italic toggle="yes">Rickettsia typhi</italic> Wilmington strain) (Biocell Diagnostics Inc.). We screened serum samples collected at time of hospitalization (acute phase) and at 1-month follow-up (convalescent phase) at a dilution of 1:64 and titrated to 1:65,536 (<xref rid="R17" ref-type="bibr"><italic toggle="yes">17</italic></xref>). We considered a sample seropositive at a threshold titer of <underline>&gt;</underline>128. We used a titer of 32 for fold-change calculations if the screen was negative. We defined a confirmed case as a seroconversion with a <underline>&gt;</underline>4-fold increase in titer from the acute to convalescent sample, in which the convalescent titer was <underline>&gt;</underline>128. If a participant had a seroconversion to both SFG and TG rickettsiae, we determined the group designation by the higher convalescent titer and then the higher acute titer. We excluded rickettsial infections with an alternative nonrickettsial positive microbiological result on the basis of our protocolized testing (malaria antigen positive, tuberculosis PCR positive or urine lipoarabinomannan positive, positive blood cultures, or positive whole blood Biofire panel) from this analysis to decrease the risk for misclassification (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref> Figure 1).</p><p>For RT-PCR, we extracted RNA (targeting mRNA and rRNA to optimize sensitivity) (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>) from 200 &#181;L acute serum and 200 &#181;L acute whole blood by using QIAamp RNA Mini Kits (QIAGEN). We conducted RT-PCR by using previously published methods (<xref rid="R18" ref-type="bibr"><italic toggle="yes">18</italic></xref>) targeting SFG rickettsia <italic toggle="yes">sca0</italic> and TG rickettsia 17-kDa outer membrane lipoprotein mRNA. We only considered samples positive if in duplicate. To develop the 16S rRNA primers and probes, we aligned genes across 41 rickettsial species and 17 clinically relevant nonrickettsial bacterial species downloaded from GenBank by using the MEGAX platform (<xref rid="R19" ref-type="bibr"><italic toggle="yes">19</italic></xref>). We identified a conserved region that was disparate from nonrickettsial species, including the forward primer 5&#8242;-gcgggtaatgccgggaactataag-3&#8242;, reverse primer 5&#8242;-ccgaactgagatgtcttttaggg-3&#8242;, and probe 5&#8242;-/56-FAM/gccggagga/zen/aggtggggacgacgtc/3IABkFQ/-3&#8242;. To determine primer species specificity or exclusivity compared with off-target organisms, we compared detection and SYBR Green melting curves by using 14 rickettsial and 4 nonrickettsial DNA controls. We used a 175-bp target sequence cloned into the pCR2.1 vector as a plasmid for quantification with a quantitative PCR master mix (Bio-Rad Laboratories). We identified a cutoff for rRNA RT-PCR by using the lowest threshold with <underline>&gt;</underline>90% detection among serially diluted whole blood samples and in serum samples from healthy donors spiked with cell-free <italic toggle="yes">R. parkeri</italic>. To determine RT-PCR clinical sensitivity and specificity, we used IFA seroconversions as the index comparator. We prioritized samples with limited volume for IFA and then 16S RT-PCR, <italic toggle="yes">sca0</italic>, and 17-kDa RT-PCR. The rRNA RT-PCR performance calculations were limited to those with sample availability for both complete paired IFA and RT-PCR testing for serum and whole blood (n = 172 participants).</p><sec><title>Case&#8211;Control Analysis</title><p>To evaluate for differences in clinical parameters, groups included samples with a follow-up serologic test and we then divided them into groups of rickettsial infections (IFA seroconversion or acute RT-PCR positive [<italic toggle="yes">sca0</italic>, 17-kDa, or whole blood 16S rRNA]), malarial infections (on the basis of a rapid diagnostic test), and nonmalarial infections (no rickettsial seroconversion and a negative malaria test). We performed summary statistics for baseline characteristics and microbiology results. We used Kruskal-Wallis testing for continuous parameters, Fisher exact test for observations &lt;5, and &#967;<sup>2</sup> test for categorical parameters. We assessed groups for balance of age, female sex, and a <underline>&gt;</underline>2 quick sequential organ failure assessment (qSOFA) score by using Fisher exact test. We compared rash and clinical laboratory parameters (white blood cell count, platelet count, aspartate transaminase, alanine transaminase, and creatinine) between the rickettsial group and the malarial group and between the rickettsial group and the nonmalarial group. The sample size was insufficient for clinical comparisons of total participants with discordant PCR and IFA serology results. Because of performance limitations of the index IFA comparator, we also determined the performance when limiting negative cases to those with microbiologically confirmed nonrickettsial infections as a secondary analysis.</p><p>To determine the discrimination accuracy for identifying rickettsial infection from nonmalarial illness, we conducted multivariable logistic regression among covariates with a significant (p&lt;0.05) result from analyses for rickettsial compared with nonmalarial illness (ultimately limited to platelet count) adjusted for age, sex, and parent cohort. We obtained receiver operating characteristic curve estimates by using 3,000-fold cross-validation. We did not perform a multiple comparisons correction because of sample size. We estimated an effect size of an odds ratio of 2.6 to be detectable with a statistical power of 80% with a 1-sided &#945; &lt;0.05 comparing 33 rickettsial infections with 8:1 matching. We conducted analyses by using Stata version 16.0 (StataCorp, LLC), and created figures by using Stata or R version 4.0.1 (The R Project for Statistical Computing).</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Serology</title><p>In the SFG, the median time from acute-phase sample collection to convalescent-phase sample collection was 28 days (interquartile range [IQR] 24&#8211;30 days). We found that 49.7% (215/433) of acute samples and 58.5% (196/335) of convalescent samples were seropositive (<underline>&gt;</underline>128) for SFG rickettsia. Among acute samples, 43.2% (187/433) were positive at <underline>&gt;</underline>256 and 40.0% (173/433) were positive at <underline>&gt;</underline>512 (<xref rid="F1" ref-type="fig">Figure 1</xref>, panel A). Among samples with a positive screen (titer <underline>&gt;</underline>64), the median acute titer was 1,024 (up to 131,072; IQR 128&#8211;4,096) and median convalescent titer was 2,048 (up to 131,072; IQR 512&#8211;8,192). Baseline acute-phase sample seropositivity was highest in the city of Arua (acute 66.7% [22/33]), followed by Fort Portal (acute 54.3% [169/311]) and Mubende (acute 27.0% [24/89]). Among samples with a positive screen, the acute geometric mean titer (GMT) was 1,137.6 (95% CI 877.0&#8211;1,475.5) and the convalescent GMT was 1,990.5 (95% CI 1,508.1&#8211;2,627.2).</p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><p>Alluvial plots of baseline acute serum samples from study of rickettsioses as an underrecognized cause of hospitalization for febrile illness, Uganda. A) Spotted fever group rickettsiae; B) typhus group rickettsiae. Immunofluorescence assay IgG seroprevalence is shown for different sites and different titer cutoffs. Participant samples were from referral hospital clinical study sites in Arua (in yellow; 7.6% of participants), Mubende (in red, 20.6% of participants), and in Fort Portal (in blue, 71.8%). Distribution of the colored lines across the graph shows a comparison of positive or negative samples among the sites. Green is the total percentage of negative samples. Orange is the total percentage of positive samples. Neg, negative; pos, positive.</p></caption><graphic position="float" orientation="portrait" xlink:href="25-0479-F1.jpg"/></fig><p>In the TG, we found that 10.6% (46/433) of acute-phase samples and 13.4% (45/335) of convalescent-phase samples were seropositive (<underline>&gt;</underline>128) for TG rickettsia. Among acute samples, 9.0% (39/433) were positive at <underline>&gt;</underline>256 and 8.3% (36/433) were positive at <underline>&gt;</underline>512 (<xref rid="F1" ref-type="fig">Figure 1</xref>, panel B). Among samples with a positive screen, the median acute titer was 512 (up to 65,536; IQR 128&#8211;4,096) and median convalescent titer was 2,048 (up to 131,072; IQR 512&#8211;8,192). Compared with SFG rickettsia serology, baseline acute phase sample TG seropositivity varied less across sites, with the highest prevalence of seropositive results in Arua (acute: 15.2% [5/33]), followed by Fort Portal (acute 11.6% [36/311]), and Mubende (acute: 5.6% [5/89]). Among positive screens, the acute GMT was 873.4 (95% CI 486.3&#8211;1,568.6) and convalescent GMT was 1,915.9 (95% CI 1,030.6&#8211;3,561.8). After excluding samples with multiple positive nonrickettsial and rickettsial results (n = 14) (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref> Figure 1), we observed SFG seroconversions (<underline>&gt;</underline>4-fold rise in titers) among 4.4% (14 participants) and TG seroconversions among 1.9% (6 participants) of participants.</p></sec><sec><title>rRNA RT-PCR Analytical Validation</title><p>To determine primer species specificity compared with off-target organisms, we conducted SYBR Green melting curves that were positive among 8 SFG species and <italic toggle="yes">R. typhi</italic> archived DNA controls and negative for 4 nonrickettsial DNA controls, 2 <italic toggle="yes">Anaplasma</italic> spp., and 2 <italic toggle="yes">Ehrlichia</italic> spp. (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref> Table 1). We identified a16S rRNA RT-PCR cycle threshold (Ct) cutoff of 35.0 as the lowest threshold to detect <underline>&gt;</underline>90% of serially diluted <italic toggle="yes">R. parkeri</italic> spiked samples in both whole blood and serum. This threshold equated to a lower limit of detection of 61 genomic equivalents/mL in whole blood and 3.8 genomic equivalents/mL in serum (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref> Table 2). Healthy control (n = 6) samples were negative.</p></sec><sec><title>rRNA RT-PCR Compared with IFA Seroconversion Cases</title><p>Among participants with complete IFA testing and sufficient volume, acute-phase whole blood and serum were available for nucleic acid extraction and RT-PCR from 172 participants (including 12 with seroconversion). Compared with IFA seroconversion as the index test, rRNA RT-PCR was 33.3% sensitive (95% CI 33.3&#8211;65.1%; 4 of 12 cases) by using whole blood and 75.0% sensitive (95% CI 42.8&#8211; 94.5%; 9 of 12 cases) by using serum. Among rickettsial rRNA RT-PCR positive seroconversion positive cases, serum Ct values were 30.2&#8211;34.4 for serum and 29.8&#8211;31.9 for whole blood.</p></sec><sec><title>Discrepant Cases </title><p>Among cases without IFA seroconversion, 4/160 whole blood samples were rRNA RT-PCR positive (97.5% specific [95% CI 93.7%&#8211;99.3%]; Ct range 31.7&#8211;34.8) and 14/160 serum samples were rRNA RT-PCR positive (91.2% specific [95% CI 85.8%&#8211;95.1%]; Ct range 29.9&#8211;34.5) (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref> Figure 2). Half or more (7 of 14 serum and 3 of 4 of whole blood) of the discrepant cases had an acute titer higher than the 95% CI of the GMT mean for the cohort. The time between the acute-phase and convalescent-phase sample collection was 23&#8211;49 days among positive serum cases and 23&#8211;29 days among positive whole blood cases. If restricting the nonrickettsial case definition to microbiologically confirmed diagnoses (n = 62), whole blood 16S rRNA was 100% specific (95% CI 94.2%&#8211;100.0%; 0 positive nonrickettsial cases) and serum 16S rRNA was 96.8% specific (95% CI 88.8%&#8211;99.6%). Two cases without <underline>&gt;</underline>4-fold change in IFA under this definition were rRNA RT-PCR positive and were infected with malaria. One had acute and convalescent SFG IgG titers of 65,636 (seroconversion was not observable because of the titration upper limit).</p></sec><sec><title><italic toggle="yes">Rickettsia</italic> mRNA RT-PCR Compared with IFA Seroconversion Cases</title><p>Among participants with both acute and convalescent serum samples, 1 was <italic toggle="yes">Rickettsia</italic> mRNA RT-PCR (17-kDa) positive. This case was also rRNA positive. On the basis of this single case, <italic toggle="yes">sca0</italic> and 17-kD protein gene transcript RT-PCR targets combined (positive with either target) were 14.3% sensitive (95% CI 0.4%&#8211;57.9%; 1 of 7 IFA cases) and 100.0% specific (95% CI 97.7%&#8211;100.0%). All samples were negative for 17-kDa or <italic toggle="yes">sca0</italic> targets when using PCR on whole blood with or without reverse transcription or on serum without reverse transcription.</p></sec><sec><title>Clinical Case&#8211;Control Rickettsial Comparisons</title><p>Participants used in the case-control comparison (n = 329) were a median of 39.0 (IQR 27&#8211;54) years of age at enrollment and 62% were female and 38% male (<xref rid="T1" ref-type="table">Table 1</xref>). Empiric tetracycline antimicrobial drugs were started across cohorts among 5.8% participants. Infection groups had similar distributions of age (p = 0.39), sex (p = 0.72) and a positive qSOFA score (p = 0.77).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><title>Baseline demographics for case&#8211;control comparison in study of rickettsioses as an underrecognized cause of hospitalization for febrile illness, Uganda*</title></caption><table frame="hsides" rules="groups"><col width="215" span="1"/><col width="101" span="1"/><col width="84" span="1"/><col width="80" span="1"/><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Sepsis cohort, n = 259</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">AFI cohort, n = 70</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Total, n = 329</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, y, median (IQR)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30.5 (24.0&#8211;47.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30.5 (24.0&#8211;47.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">39.0 (27.0&#8211;54.0)<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex, no. (%)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> F</td><td valign="top" align="center" rowspan="1" colspan="1">160 (62)</td><td valign="top" align="center" rowspan="1" colspan="1">43 (61)</td><td valign="top" align="center" rowspan="1" colspan="1">203 (62)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> M<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">99 (38)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27 (39)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">126 (38)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">HIV-positive, no. (%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95 (37)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23 (33)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">118 (36)<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Physiologic parameters, median (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Heart rate, beats/min</td><td valign="top" align="center" rowspan="1" colspan="1">101.0 (90.0&#8211;112.0)</td><td valign="top" align="center" rowspan="1" colspan="1">109.0 (93.0&#8211;116.0)</td><td valign="top" align="center" rowspan="1" colspan="1">101.0 (90.0&#8211;114.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Temperature, &#176;C</td><td valign="top" align="center" rowspan="1" colspan="1">37.5 (36.9&#8211;38.1)</td><td valign="top" align="center" rowspan="1" colspan="1">38.1 (38.0&#8211;38.8)</td><td valign="top" align="center" rowspan="1" colspan="1">37.6 (36.9&#8211;38.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Breaths/min</td><td valign="top" align="center" rowspan="1" colspan="1">28.0 (24.0&#8211;32.0)</td><td valign="top" align="center" rowspan="1" colspan="1">20.0 (18.0&#8211;24.0)</td><td valign="top" align="center" rowspan="1" colspan="1">26.0 (22.0&#8211;32.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Oxygen saturation<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95.0 (92.0&#8211;97.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (97.0&#8211;99.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95.0 (93.0&#8211;98.0)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">qSOFA <underline>&gt;</underline>2, no. (%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53 (21)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12 (17)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65 (20)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tetracycline treatment, no. (%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (6.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.4)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (5.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rickettsial&#8224; treatment, no. (%)</td><td valign="top" align="center" rowspan="1" colspan="1">126 (49)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (26)</td><td valign="top" align="center" rowspan="1" colspan="1">144 (44)</td></tr></tbody></table><table-wrap-foot><p>*AFI, acute febrile illness; IQR, interquartile range; qSOFA, quick sepsis organ failure assessment.
&#8224;Antimicrobial drugs with potential rickettsial activity: tetracyclines, macrolides, or quinolones. </p></table-wrap-foot></table-wrap><p>On the basis of the high specificity of whole blood rRNA, serum <italic toggle="yes">sca0</italic>, and serum 17-kDa RT-PCR, we expanded our serologic case definition for a case&#8211;control comparison to include those assays (<xref rid="SD1" ref-type="supplementary-material">Appendix</xref> Figure 1). Among patients with acute-phase samples with or without convalescent serum samples, 8.0% (33/412; 20 patients identified with a <underline>&gt;</underline>4-fold change in IFA) had rickettsial infections. To evaluate for differences in clinical parameters, we made comparisons among groups of rickettsial infections, malarial infections on the basis of a rapid diagnostic test (n = 59), and nonmalarial infections (no rickettsial seroconversion and a negative malaria test, n = 237).</p><p>Among those with confirmed rickettsial infections, severity was similar to nonrickettsial infections; 22% had a qSOFA of <underline>&gt;</underline>2 (<xref rid="T2" ref-type="table">Table 2</xref>). No participants with rickettsial infections were on tetracycline treatments, and a minority (36%) had received a potentially active antimicrobial drug (i.e., macrolide, quinolone, or chloramphenicol) against rickettsial infections. Rash (including maculopapular because of <italic toggle="yes">R. conorii</italic> infection) (<xref rid="R7" ref-type="bibr"><italic toggle="yes">7</italic></xref>) was observed in only 6% of participants.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><title>Clinical characteristics among those with rickettsial, malarial, and nonmalarial illness in study of rickettsioses as an underrecognized cause of hospitalization for febrile illness, Uganda*</title></caption><table frame="hsides" rules="groups"><col width="103" span="1"/><col width="76" span="1"/><col width="76" span="1"/><col width="72" span="1"/><col width="81" span="1"/><col width="72" span="1"/><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Rickettsial, n = 33</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Malarial, n = 59</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">p value, rickettsial vs. malarial&#8224;</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Nonmalarial, n = 237</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">p value, rickettsial vs. nonmalarial&#8224;</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, y, median (IQR)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">37.0 (28.0&#8211;47.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">35.0 (24.0&#8211;51.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.794<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">40.0 (28.0&#8211;55.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.393<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> F</td><td valign="top" align="center" rowspan="1" colspan="1">21/33 (64)</td><td valign="top" align="center" rowspan="1" colspan="1">39/59 (66)</td><td valign="top" align="center" rowspan="1" colspan="1">0.812</td><td valign="top" align="center" rowspan="1" colspan="1">143/237 (60)</td><td valign="top" align="center" rowspan="1" colspan="1">0.716</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> M<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12 (36)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20 (34)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.812<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94 (40)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.716<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">HIV-positive <hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10/33 (30)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17/59 (29)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.880<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91/237 (38)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.368<hr/></td></tr><tr><td colspan="2" valign="top" align="left" scope="col" rowspan="1">Physiologic parameters, median (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Heart rate, beats/min</td><td valign="top" align="center" rowspan="1" colspan="1">102.0 (91.0&#8211;110.0)</td><td valign="top" align="center" rowspan="1" colspan="1">102.0 (92.0&#8211;113.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.782</td><td valign="top" align="center" rowspan="1" colspan="1">101.0 (89.0&#8211;114.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.696</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Temperature &#176;C</td><td valign="top" align="center" rowspan="1" colspan="1">38.0 (37.1&#8211;38.8)</td><td valign="top" align="center" rowspan="1" colspan="1">38.0 (37.0&#8211;38.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.964</td><td valign="top" align="center" rowspan="1" colspan="1">37.5 (36.9&#8211;38.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.083</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Breaths/min</td><td valign="top" align="center" rowspan="1" colspan="1">24.0 (20.0&#8211;29.0)</td><td valign="top" align="center" rowspan="1" colspan="1">24.0 (20.0&#8211;32.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.954</td><td valign="top" align="center" rowspan="1" colspan="1">28.0 (24.0&#8211;32.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.057</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Oxygen saturation<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95.0 (93.0&#8211;98.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">97.0 (94.0&#8211;98.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.134<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95.0 (92.0&#8211;97.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.535<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">qSOFA &#8805;2, no. (%)&#8225;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7/33 (21)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13/59 (22)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.927<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">45/236 (19)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.770<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tetracycline treatment </td><td valign="top" align="center" rowspan="1" colspan="1">0/33 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">0/59 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">&gt;0.999</td><td valign="top" align="center" rowspan="1" colspan="1">19/237 (8.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.142</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rickettsial treatment </td><td valign="top" align="center" rowspan="1" colspan="1">12/33 (36)</td><td valign="top" align="center" rowspan="1" colspan="1">14/59 (24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.197</td><td valign="top" align="center" rowspan="1" colspan="1">118/237 (50)</td><td valign="top" align="center" rowspan="1" colspan="1">0.148</td></tr></tbody></table><table-wrap-foot><p>*Values are no. positive/no. tested (%) except as indicated. IQR, interquartile range; qSOFA, quick sepsis organ failure assessment.
&#8224;Fisher exact test, Wilcoxon rank-sum test, or Pearson &#967;<sup>2</sup> test.
&#8225;Missing for 1 of 328 participants.</p></table-wrap-foot></table-wrap><p>Among patients with rickettsial illness, median leukocyte count was 6.2 &#215; 10<sup>3</sup> cells/&#181;L (IQR 4.6&#8211;8.1 &#215; 10<sup>3</sup> cells/&#181;L), aspartate transaminase 38 U/L (IQR 26.0&#8211;92.0 U/L), and platelet count 168.0 &#215; 10<sup>3</sup>/&#181;L (IQR 116.9&#8211;264.5 &#215; 10<sup>3</sup>/&#181;L) (<xref rid="T3" ref-type="table">Table 3</xref>). Among SFG seroconversions, the median acute titer was 384 (IQR 128&#8211;2,048) and median convalescent titer was 1,536 (IQR 1,024&#8211;16,384). Among TG cases, the median acute titer was 64 (IQR 32&#8211;8,192) and median convalescent titer was 4,096 (IQR 1,024&#8211;65,536). Thrombocytopenia was more common among those with rickettsial infections compared with other nonmalarial infections (adjusted odds ratio 3.7; p = 0.003), but diagnostic performance was limited (sensitivity 45.5%, 95% CI 24.4&#8211;67.8%; specificity 83.6%, 95% CI 78.1&#8211;88.1%; positive likelihood ratio 2.8, 95% CI 1.6&#8211;4.8; negative likelihood ratio 0.7, 95% CI 0.4&#8211;1.0). The cross-validated area under the receiver operating characteristic curve was 0.68 (95% CI 0.46&#8211;0.74). In addition, the platelet count was lower among patients with malarial illness than rickettsial illness (p = 0.007) (<xref rid="T3" ref-type="table">Table 3</xref>; <xref rid="F2" ref-type="fig">Figure 2</xref>). Leukocyte count was higher among patients with rickettsial infections than malarial illness (median 4.7 &#215; 10<sup>3</sup> cells/&#181;L, IQR 3.3&#8211;6.6 &#215; 10<sup>3</sup> cells/&#181;L; p = 0.013). Other parameters were not significantly different. Of participants with rickettsial infections, 3 of 33 died within 90 days.</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><title>Clinical examination and laboratory features among diagnostic classes in a study of rickettsioses as an underrecognized cause of hospitalization for febrile illness, Uganda *</title></caption><table frame="hsides" rules="groups"><col width="99" span="1"/><col width="67" span="1"/><col width="67" span="1"/><col width="72" span="1"/><col width="54" span="1"/><col width="67" span="1"/><col width="54" span="1"/><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Total, n = 329</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Malarial, n = 59</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Rickettsial, n = 33</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">p value, rickettsial vs. malarial&#8224;</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Nonmalarial, n = 237</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">p value, rickettsial vs. nonmalarial&#8224;</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rash on examination, no. (%)&#8225;</td><td valign="top" align="center" rowspan="1" colspan="1">21/328 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2/59 (3.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2/33 (6.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.616</td><td valign="top" align="center" rowspan="1" colspan="1">17/236 (7.2)</td><td valign="top" align="center" rowspan="1" colspan="1">&gt;0.999</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Leukocytes, &#215; 10<sup>3</sup> cells/&#181;L&#167;</td><td valign="top" align="center" rowspan="1" colspan="1">5.5 (3.9&#8211;8.4)</td><td valign="top" align="center" rowspan="1" colspan="1">4.7 (3.3&#8211;6.6)</td><td valign="top" align="center" rowspan="1" colspan="1">6.2 (4.6&#8211;8.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.012</td><td valign="top" align="center" rowspan="1" colspan="1">5.6 (4.1&#8211;9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.900</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Platelet count, &#215; 10<sup>3</sup> cells/&#181;L &#182;</td><td valign="top" align="center" rowspan="1" colspan="1">205.0 (134.7&#8211;289.0)</td><td valign="top" align="center" rowspan="1" colspan="1">104.1 (64.2&#8211;179.0)</td><td valign="top" align="center" rowspan="1" colspan="1">168.0 (116.9&#8211;264.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.007</td><td valign="top" align="center" rowspan="1" colspan="1">227.0 (171.0&#8211;311.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.013</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">AST, U/L &#8225;#</td><td valign="top" align="center" rowspan="1" colspan="1">35.0 (26.0&#8211;59.0)</td><td valign="top" align="center" rowspan="1" colspan="1">32.0 (24.0&#8211;42.0)</td><td valign="top" align="center" rowspan="1" colspan="1">38.0 (26.0&#8211;92.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.081</td><td valign="top" align="center" rowspan="1" colspan="1">36.0 (26.0&#8211;61.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.524</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">ALT, U/L</td><td valign="top" align="center" rowspan="1" colspan="1">23.0 (18.0&#8211;36.0)</td><td valign="top" align="center" rowspan="1" colspan="1">21.0 (17.0&#8211;28.0)</td><td valign="top" align="center" rowspan="1" colspan="1">25.0 (19.0&#8211;44.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.119</td><td valign="top" align="center" rowspan="1" colspan="1">24.0 (18.0&#8211;37.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.596</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Creatinine, mg/dL**</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 (0.5&#8211;1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 (0.0&#8211;1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 (0.0&#8211;1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.204</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 (0.6&#8211;1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.541</td></tr></tbody></table><table-wrap-foot><p>*Values are median (interquartile range) except as indicated. ALT, alanine transaminase; AST, aspartate transaminase; qSOFA, quick sepsis organ failure assessment.
&#8224;Fisher exact test, Wilcoxon rank-sum test, or Pearson &#967;<sup>2</sup> test.
&#8225;No. positive/no. tested (%). Missing for 1 of 329 participants.
&#167;Missing for 18 of 328 participants.
&#182;Missing for 19 of 328 participants.
#Missing for 1 of 329 participants.
**Missing for 2 of 322 participants.</p></table-wrap-foot></table-wrap><fig position="float" id="F2" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><p>Box plot of platelet counts from patient samples by infection type in study of rickettsioses as an underrecognized cause of hospitalization for febrile illness, Uganda. Horizontal lines within boxes indicate median; box tops and bottoms indicate interquartile ranges; error bar above is 1.5x the IQR to the highest value and the error bar below is 1.5x the IQR to the lowest value.</p></caption><graphic position="float" orientation="portrait" xlink:href="25-0479-F2.jpg"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study found that rickettsioses were a common cause of hospitalized illness across multiple sites in Uganda, consistent with a high observed seroprevalence. Rickettsial illness manifested similarly to nonmalarial illness on the basis of well-described clinical parameters. Clinical factors (including platelet count) were neither sensitive nor specific for identifying rickettsial infections. Rashes were infrequently reported or seen on physical examination, and no eschars were observed. Specific rickettsial treatments were uncommonly used. rRNA RT-PCR sensitivity in serum samples was considerably higher than targeting rickettsial mRNAs, although the use of rRNA RT-PCR has the potential benefit as a diagnostic strategy for identifying acute cases that otherwise would not be treated. Our findings highlight the need for continued diagnostic development. Clinicians should also have a high level of suspicion and low threshold for empiric doxycycline use in this region for nonmalarial illness among hospitalized adults.</p><p>Among prior cohorts in Sub-Saharan Africa, clinical descriptions of rickettsial infections have largely been limited to returning travelers, and the course of hospitalized illness is not prospectively well characterized. The high rates of seroprevalence observed and common identification of seroconversions indicate that rickettsial infections are circulating widely in this region. A high number of rickettsial infections is supported by a recent study that identified SFG rickettsia in ticks throughout Uganda (<xref rid="R20" ref-type="bibr"><italic toggle="yes">20</italic></xref>). We found rickettsial infections were common (8%) among patients with acute febrile illness or sepsis manifestations. This result is similar to an estimate from 2012&#8211;2014 among pediatric and adult febrile participants in Tanzania in which 8.9% had SFG rickettsia seroconversions (<xref rid="R21" ref-type="bibr"><italic toggle="yes">21</italic></xref>). Our findings greatly strengthen the evidence that rickettsial infections frequently cause hospitalization in this region.</p><p>Novel acute diagnostics are needed to identify rickettsioses. Diagnostic delays for rickettsial infections often result in prolonged hospital stays and increased death because rickettsial infections are not susceptible to standard empiric antimicrobial drugs used in many worldwide settings (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>,<xref rid="R22" ref-type="bibr"><italic toggle="yes">22</italic></xref>,<xref rid="R23" ref-type="bibr"><italic toggle="yes">23</italic></xref>). The current diagnostic standard, indirect IFA, relies on referral acute and convalescent serum sample confirmation testing, which is only available 3&#8211;6 weeks after symptom onset and has performance limitations (<xref rid="R9" ref-type="bibr"><italic toggle="yes">9</italic></xref>). Our observations of rRNA RT-PCR&#8211;positive IFA-negative participants highlighted challenges with using a 4-fold IFA titer increase. In addition to logistical barriers, IFA interpretation could be affected by blood collection timing (<xref rid="R24" ref-type="bibr"><italic toggle="yes">24</italic></xref>), early receipt of antimicrobial drugs (<xref rid="R25" ref-type="bibr"><italic toggle="yes">25</italic></xref>), and immunocompromising conditions (<xref rid="R26" ref-type="bibr"><italic toggle="yes">26</italic></xref>). Characteristics of rickettsial infection were not reliable as clues for initiating empiric treatment, further demonstrating the diagnostic gap and need to consider empiric treatment without fully relying on clinical laboratory results in the absence of a sensitive rapid diagnostic test.</p><p>We demonstrated potential improvement in sensitivity by using RT-PCR rather than PCR and by using highly abundant and stable rickettsial rRNA targets rather than membrane protein gene DNA or mRNA targets. Molecular amplification typically has low sensitivity (&#8776;7%&#8211;43%) for rickettsioses because of low organism burden; sensitivity can be improved by extracting nucleic acid from the buffy coat, which requires additional processing (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>,<xref rid="R18" ref-type="bibr"><italic toggle="yes">18</italic></xref>). By using multiple singleplex RT-PCR primers (targeting membrane protein gene DNA or mRNA) we were able to detect cases not identified with DNA PCR. However, sensitivity remains limited with either RT-PCR or PCR by using traditional targets present in either low numbers or that are labile. We anticipated whole blood would contain more rickettsial organisms and improve sensitivity compared with serum across PCR targets. Instead, we found that whole blood was less sensitive than serum, potentially because of inhibitors in whole blood (<xref rid="R27" ref-type="bibr"><italic toggle="yes">27</italic></xref>). rRNA RT-PCR improved sensitivity of PCR over membrane protein gene DNA and mRNA targets and demonstrated promise as an acute detection diagnostic modality that detected rickettsial cases missed by DNA, but mRNA detection was not higher than anticipated when compared with previous studies using DNA (<xref rid="R18" ref-type="bibr"><italic toggle="yes">18</italic></xref>).</p><p>Our results are supported by prior efforts that showed improved performance by using 23S rRNA targets (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>,<xref rid="R16" ref-type="bibr"><italic toggle="yes">16</italic></xref>). The stability and abundance of protein-associated rickettsial rRNA targets are promising for use in remote settings where sample handling and storage can be more vulnerable to unstable conditions. However, rRNA still lacks sensitivity compared with paired serologic testing. Scalable methods to improve specificity and potentially sensitivity such as digital droplet PCR or concentrating target templates in each reaction are needed before broad clinical use (<xref rid="R18" ref-type="bibr"><italic toggle="yes">18</italic></xref>). However, because RT-PCR is now widely available, potentially with increased capacity after the COVID-19 pandemic, and doxycycline is generally well tolerated, laboratory-validated rRNA RT-PCR could be used to initiate standard of care treatment with doxycycline and then serologic confirmation. Rickettsial rRNA genes are abundant stable targets that could be leveraged for furthering clinical rickettsial diagnostics, but implementation and validation studies are needed at clinical sites. Although performance could be optimized, rickettsial rRNA RT-PCR might be the best option for clinical use in highly endemic regions in the absence of a reliable acute diagnostic alternative.</p><p>The first limitation of our study is that it relied on availability of convalescent-phase serologic testing to identify approximately half of the infected patients. Therefore, the severity of each group is not anticipated to be representative of the population because participants lost to follow-up or who had died before 28 days were not included. Second, in emphasizing sample availability for multimodal case identification, our study was not designed to determine differences in deaths or duration of hospital stay. Third, sample collection, handling and storing conditions at resource-limited clinical sites might have decreased PCR sensitivity. rRNA RT-PCR performance could be improved with direct testing after collection, although rRNA is likely less vulnerable to degradation than mRNA. Last, conserved rRNA targets afford broad detection of rickettsioses but are intrinsically less phylogenetically or taxonomically informative, prohibiting the possibility for species level identification of SFG rickettsiae.</p><p>In conclusion, we found rickettsial infections to be common across 2 severe infectious illness cohorts in Uganda. Our case&#8211;control study identified that commonly suggested clinical factors for identifying rickettsial infections in sub-Saharan Africa are nonspecific or are generally absent. rRNA RT-PCR improved sensitivity over previously used membrane protein gene DNA PCR and mRNA RT-PCR and requires further clinical validation to ensure specificity when using conserved stable rRNA targets. Until acute diagnostics are widely available for rickettsial infections, empiric doxycycline should be considered for nonmalarial fever of unknown cause in this region.</p></sec><sec sec-type="supplementary-material"><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><caption><title>Appendix</title><p>Additional information about rickettsioses as underrecognized cause of hospitalization for febrile illness, Uganda.</p></caption><media xlink:href="25-0479-Techapp-s1.pdf" id="d67e940" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack><p>Members of the Acute Febrile Illness and Sepsis in Uganda Study Team: Danielle V. Clark, Emily Clemens, Melissa Gregory, Francis Kakooza, Willy Kayondo, Mubaraka Kayiira, Hannah Kibuuka, Kenneth Kobba, Abraham Khandathil, Mohammed Lamorde, Prossy Naluyima, Edgar C. Ndawula, Stephen Okello, Matt L. Robinson, and Peter Waitt.</p><p>This project was supported by the Congressionally Directed Medical Research Programs Tickborne Diseases Related Program Career Development Award. Pathogen testing was supported by the Naval Medical Logistics Command (cooperative agreement no. N626451920001) within the parent protocol.</p><p>The sepsis protocol and informed consent were approved by the US Army Medical Research and Development Command Institutional Review (approval no. M-10573) and Makerere University School of Public Health (internal review board approval no. 490). The acute febrile illness study and informed consent process were reviewed and approved by the Joint Clinical Research Centre Research Ethics Committee (approval no. JC1518) and the Uganda National Council for Science and Technology (approval no. HS 371ES), and Johns Hopkins University School of Medicine (internal review board no. IRB00176961). All participants signed written informed consent forms before study procedures. All participants were provided written consent that was in either English or their local language. All procedures were conducted in accordance with the ethical standards of the Helsinki Declaration of the World Medical Association. The investigators have adhered to the policies for protection of human subjects as prescribed in 45 code of federal regulations 46.</p><p>Y.C.M. receives research funding from Becton Dickinson, Quanterix, and Hologic, and receives funding support from miDiagnostics to Johns Hopkins University. M.L. receives research funding support from Pfizer Inc. to the Infectious Diseases Institute.</p></ack><fn-group><fn fn-type="other"><p><italic toggle="yes">Suggested citation for this article</italic>: Blair PW, Alharthi S, Londo&#241;o AF, Wailagala A, Manabe YC, Dumler JS, et al. Rickettsioses as underrecognized cause of hospitalization for febrile illness, Uganda. Emerg Infect Dis. 2025 Sep [<italic toggle="yes">date cited</italic>]. <ext-link xlink:href="https://doi.org/10.3201/eid3109.250479" ext-link-type="uri">https://doi.org/10.3201/eid3109.250479</ext-link></p></fn><fn id="FN1"><label>1</label><p>Members are listed at the end of this article.</p></fn></fn-group><bio id="d67e959"><p>Dr. Blair is an infectious disease physician and scientist at Vanderbilt University Medical Center, Nashville, Tennessee, USA. His research interests include molecular and imaging approaches to clinically detect acute and emerging infectious diseases.</p></bio><ref-list><title>References</title><ref id="R1"><label>1. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hercik</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cosmas</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mogeni</surname><given-names>OD</given-names></string-name>, <string-name name-style="western"><surname>Wamola</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kohi</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Houpt</surname><given-names>E</given-names></string-name>, <etal>et al.</etal><article-title>A combined syndromic approach to examine viral, bacterial, and parasitic agents among febrile patients: a pilot study in Kilombero, Tanzania.</article-title><source>Am J Trop Med Hyg</source>. <year>2018</year>;<volume>98</volume>:<fpage>625</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.17-0421</pub-id><pub-id pub-id-type="pmid">29280432</pub-id><pub-id pub-id-type="pmcid">PMC5929188</pub-id></mixed-citation></ref><ref id="R2"><label>2. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Freedman</surname><given-names>DO</given-names></string-name>, <string-name name-style="western"><surname>Weld</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Kozarsky</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Fisk</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Robins</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>von Sonnenburg</surname><given-names>F</given-names></string-name>, <etal>et al.</etal>; <collab>GeoSentinel Surveillance Network</collab>. <article-title>Spectrum of disease and relation to place of exposure among ill returned travelers.</article-title><source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>119</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa051331</pub-id><pub-id pub-id-type="pmid">16407507</pub-id></mixed-citation></ref><ref id="R3"><label>3. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mendelson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>XM</given-names></string-name>, <string-name name-style="western"><surname>Jensenius</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Keystone</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>von Sonnenburg</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Hale</surname><given-names>DC</given-names></string-name>, <etal>et al.</etal>; <collab>GeoSentinel Surveillance Network</collab>. <article-title>Health risks in travelers to South Africa: the GeoSentinel experience and implications for the 2010 FIFA World Cup.</article-title><source>Am J Trop Med Hyg</source>. <year>2010</year>;<volume>82</volume>:<fpage>991</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2010.10-0198</pub-id><pub-id pub-id-type="pmid">20519590</pub-id><pub-id pub-id-type="pmcid">PMC2877439</pub-id></mixed-citation></ref><ref id="R4"><label>4. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bogovic</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lotric-Furlan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Korva</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Avsic-Zupanc</surname><given-names>T</given-names></string-name>. <article-title>African tick-bite fever in traveler returning to Slovenia from Uganda.</article-title><source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>:<fpage>1848</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid2210.160650</pub-id><pub-id pub-id-type="pmid">27648844</pub-id><pub-id pub-id-type="pmcid">PMC5038416</pub-id></mixed-citation></ref><ref id="R5"><label>5. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>de Vries</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>van Eekeren</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>van der Linden</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Visser</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Grobusch</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Wagenaar</surname><given-names>JFP</given-names></string-name>, <etal>et al.</etal><article-title>Searching and finding the hidden treasure: a retrospective analysis of rickettsial disease among Dutch international travelers.</article-title><source>Clin Infect Dis</source>. <year>2021</year>;<volume>72</volume>:<fpage>1171</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciaa091</pub-id><pub-id pub-id-type="pmid">31998942</pub-id><pub-id pub-id-type="pmcid">PMC8028097</pub-id></mixed-citation></ref><ref id="R6"><label>6. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Raoult</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fournier</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Fenollar</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Jensenius</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Prioe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>de Pina</surname><given-names>JJ</given-names></string-name>, <etal>et al.</etal><article-title><italic toggle="yes">Rickettsia africae</italic>, a tick-borne pathogen in travelers to sub-Saharan Africa.</article-title><source>N Engl J Med</source>. <year>2001</year>;<volume>344</volume>:<fpage>1504</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM200105173442003</pub-id><pub-id pub-id-type="pmid">11357153</pub-id></mixed-citation></ref><ref id="R7"><label>7. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kandathil</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Blair</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Anantharam</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kobba</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>ML</given-names></string-name>, <etal>et al.</etal><article-title>Metagenomic next generation sequencing of plasma RNA for diagnosis of unexplained, acute febrile illness in Uganda.</article-title><source>PLoS Negl Trop Dis</source>. <year>2024</year>;<volume>18</volume>:<elocation-id>e0012451</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0012451</pub-id><pub-id pub-id-type="pmid">39298515</pub-id><pub-id pub-id-type="pmcid">PMC11460704</pub-id></mixed-citation></ref><ref id="R8"><label>8. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Parola</surname><given-names>P</given-names></string-name>. <article-title>Rickettsioses in sub-Saharan Africa.</article-title><source>Ann N Y Acad Sci</source>. <year>2006</year>;<volume>1078</volume>:<fpage>42</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1374.005</pub-id><pub-id pub-id-type="pmid">17114679</pub-id></mixed-citation></ref><ref id="R9"><label>9. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Biggs</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Behravesh</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Bradley</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Dahlgren</surname><given-names>FS</given-names></string-name>, <string-name name-style="western"><surname>Drexler</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Dumler</surname><given-names>JS</given-names></string-name>, <etal>et al.</etal><article-title>Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis&#8212;United States.</article-title><source>MMWR Recomm Rep</source>. <year>2016</year>;<volume>65</volume>:<fpage>1</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.rr6502a1</pub-id><pub-id pub-id-type="pmid">27172113</pub-id></mixed-citation></ref><ref id="R10"><label>10. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Paris</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Dumler</surname><given-names>JS</given-names></string-name>. <article-title>State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus.</article-title><source>Curr Opin Infect Dis</source>. <year>2016</year>;<volume>29</volume>:<fpage>433</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0000000000000298</pub-id><pub-id pub-id-type="pmid">27429138</pub-id><pub-id pub-id-type="pmcid">PMC5029442</pub-id></mixed-citation></ref><ref id="R11"><label>11. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Blair</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Lamorde</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dumler</surname><given-names>JS</given-names></string-name>. <article-title>Rickettsioses and Q fever in Tanzania: estimating the burden of pervasive and neglected causes of severe febrile illness in sub-Saharan Africa.</article-title><source>Am J Trop Med Hyg</source>. <year>2021</year>;<volume>106</volume>:<fpage>371</fpage>&#8211;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.21-0963</pub-id><pub-id pub-id-type="pmid">34929671</pub-id><pub-id pub-id-type="pmcid">PMC8832924</pub-id></mixed-citation></ref><ref id="R12"><label>12. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jacob</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Banura</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Pinkerton</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Meya</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Opendi</surname><given-names>P</given-names></string-name>, <etal>et al.</etal>; <collab>Promoting Resource-Limited Interventions for Sepsis Management in Uganda (PRISM-U) Study Group</collab>. <article-title>Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.</article-title><source>PLoS One</source>. <year>2009</year>;<volume>4</volume>:<elocation-id>e7782</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007782</pub-id><pub-id pub-id-type="pmid">19907656</pub-id><pub-id pub-id-type="pmcid">PMC2771355</pub-id></mixed-citation></ref><ref id="R13"><label>13. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Blair</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Kobba</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kakooza</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Candia</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Mayito</surname><given-names>J</given-names></string-name>, <etal>et al.</etal><article-title>Aetiology of hospitalized fever and risk of death at Arua and Mubende tertiary care hospitals in Uganda from August 2019 to August 2020.</article-title><source>BMC Infect Dis</source>. <year>2022</year>;<volume>22</volume>:<fpage>869</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-022-07877-3</pub-id><pub-id pub-id-type="pmid">36411415</pub-id><pub-id pub-id-type="pmcid">PMC9680122</pub-id></mixed-citation></ref><ref id="R14"><label>14. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chung</surname><given-names>IH</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Stewart-Juba</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Dasch</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Kato</surname><given-names>CY</given-names></string-name>. <article-title>Analytically sensitive <italic toggle="yes">Rickettsia</italic> species detection for laboratory diagnosis.</article-title><source>Am J Trop Med Hyg</source>. <year>2022</year>;<volume>106</volume>:<fpage>1352</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.21-0757</pub-id><pub-id pub-id-type="pmid">35292596</pub-id><pub-id pub-id-type="pmcid">PMC9128713</pub-id></mixed-citation></ref><ref id="R15"><label>15. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Backstedt</surname><given-names>BT</given-names></string-name>, <string-name name-style="western"><surname>Buyuktanir</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Lindow</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wunder</surname><given-names>EA</given-names><suffix>Jr</suffix></string-name>, <string-name name-style="western"><surname>Reis</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Usmani-Brown</surname><given-names>S</given-names></string-name>, <etal>et al.</etal><article-title>Efficient detection of pathogenic leptospires using 16s ribosomal RNA.</article-title><source>PLoS One</source>. <year>2015</year>;<volume>10</volume>:<elocation-id>e0128913</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0128913</pub-id><pub-id pub-id-type="pmid">26091292</pub-id><pub-id pub-id-type="pmcid">PMC4474562</pub-id></mixed-citation></ref><ref id="R16"><label>16. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kato</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>IH</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Austin</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Dasch</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Massung</surname><given-names>RF</given-names></string-name>. <article-title>Assessment of real-time PCR assay for detection of <italic toggle="yes">Rickettsia</italic> spp. and <italic toggle="yes">Rickettsia rickettsii</italic> in banked clinical samples.</article-title><source>J Clin Microbiol</source>. <year>2013</year>;<volume>51</volume>:<fpage>314</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.01723-12</pub-id><pub-id pub-id-type="pmid">23135935</pub-id><pub-id pub-id-type="pmcid">PMC3536194</pub-id></mixed-citation></ref><ref id="R17"><label>17. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Blair</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Kobba</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Okello</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Alharthi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Naluyima</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Clemens</surname><given-names>E</given-names></string-name>, <etal>et al.</etal>; <collab>Sepsis in Uganda study teams</collab>. <article-title>Sepsis in Uganda study teams. Evidence of <italic toggle="yes">Orientia</italic> spp. endemicity among severe infectious disease cohorts, Uganda.</article-title><source>Emerg Infect Dis</source>. <year>2024</year>;<volume>30</volume>:<fpage>1442</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3201/eid3007.231040</pub-id><pub-id pub-id-type="pmid">38916638</pub-id><pub-id pub-id-type="pmcid">PMC11210639</pub-id></mixed-citation></ref><ref id="R18"><label>18. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Reller</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Dumler</surname><given-names>JS</given-names></string-name>. <article-title>Optimization and evaluation of a multiplex quantitative PCR assay for detection of nucleic acids in human blood samples from patients with spotted fever rickettsiosis, typhus rickettsiosis, scrub typhus, monocytic ehrlichiosis, and granulocytic anaplasmosis.</article-title><source>J Clin Microbiol</source>. <year>2020</year>;<volume>58</volume>:<fpage>e01802</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.01802-19</pub-id><pub-id pub-id-type="pmid">32493778</pub-id><pub-id pub-id-type="pmcid">PMC7448621</pub-id></mixed-citation></ref><ref id="R19"><label>19. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kumar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Stecher</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Knyaz</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tamura</surname><given-names>K</given-names></string-name>. <article-title>MEGA X: molecular evolutionary genetics analysis across computing platforms.</article-title><source>Mol Biol Evol</source>. <year>2018</year>;<volume>35</volume>:<fpage>1547</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msy096</pub-id><pub-id pub-id-type="pmid">29722887</pub-id><pub-id pub-id-type="pmcid">PMC5967553</pub-id></mixed-citation></ref><ref id="R20"><label>20. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Eneku</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Erima</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Byaruhanga</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Atim</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Tugume</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ukuli</surname><given-names>QA</given-names></string-name>, <etal>et al.</etal><article-title>Wide distribution of Mediterranean and African spotted fever agents and the first identification of Israeli spotted fever agent in ticks in Uganda.</article-title><source>PLoS Negl Trop Dis</source>. <year>2023</year>;<volume>17</volume>:<elocation-id>e0011273</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0011273</pub-id><pub-id pub-id-type="pmid">37498943</pub-id><pub-id pub-id-type="pmcid">PMC10409254</pub-id></mixed-citation></ref><ref id="R21"><label>21. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pisharody</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rubach</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Carugati</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nicholson</surname><given-names>WL</given-names></string-name>, <string-name name-style="western"><surname>Perniciaro</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Biggs</surname><given-names>HM</given-names></string-name>, <etal>et al.</etal><article-title>Incidence estimates of acute Q fever and spotted fever group rickettsioses, Kilimanjaro, Tanzania, from 2007 to 2008 and from 2012 to 2014.</article-title><source>Am J Trop Med Hyg</source>. <year>2021</year>;<volume>106</volume>:<fpage>494</fpage>&#8211;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.20-1036</pub-id><pub-id pub-id-type="pmid">34929672</pub-id><pub-id pub-id-type="pmcid">PMC8832940</pub-id></mixed-citation></ref><ref id="R22"><label>22. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jensenius</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>PV</given-names></string-name>, <string-name name-style="western"><surname>Schlagenhauf</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Schwartz</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Parola</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Castelli</surname><given-names>F</given-names></string-name>, <etal>et al.</etal>; <collab>GeoSentinel Surveillance Network</collab>. <article-title>Acute and potentially life-threatening tropical diseases in western travelers&#8212;a GeoSentinel multicenter study, 1996-2011.</article-title><source>Am J Trop Med Hyg</source>. <year>2013</year>;<volume>88</volume>:<fpage>397</fpage>&#8211;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.12-0551</pub-id><pub-id pub-id-type="pmid">23324216</pub-id><pub-id pub-id-type="pmcid">PMC3583336</pub-id></mixed-citation></ref><ref id="R23"><label>23. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Leder</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Torresi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Libman</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Cramer</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Castelli</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Schlagenhauf</surname><given-names>P</given-names></string-name>, <etal>et al.</etal>; <collab>GeoSentinel Surveillance Network</collab>. <article-title>GeoSentinel surveillance of illness in returned travelers, 2007-2011.</article-title><source>Ann Intern Med</source>. <year>2013</year>;<volume>158</volume>:<fpage>456</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-158-6-201303190-00005</pub-id><pub-id pub-id-type="pmid">23552375</pub-id><pub-id pub-id-type="pmcid">PMC4629801</pub-id></mixed-citation></ref><ref id="R24"><label>24. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fournier</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Jensenius</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Laferl</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Vene</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Raoult</surname><given-names>D</given-names></string-name>. <article-title>Kinetics of antibody responses in <italic toggle="yes">Rickettsia africae</italic> and <italic toggle="yes">Rickettsia conorii</italic> infections.</article-title><source>Clin Diagn Lab Immunol</source>. <year>2002</year>;<volume>9</volume>:<fpage>324</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">11874871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.9.2.324-328.2002</pub-id><pub-id pub-id-type="pmcid">PMC119950</pub-id></mixed-citation></ref><ref id="R25"><label>25. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Philip</surname><given-names>RN</given-names></string-name>, <string-name name-style="western"><surname>Casper</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>MacCormack</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Sexton</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Anacker</surname><given-names>RL</given-names></string-name>, <etal>et al.</etal><article-title>A comparison of serologic methods for diagnosis of Rocky Mountain spotted fever.</article-title><source>Am J Epidemiol</source>. <year>1977</year>;<volume>105</volume>:<fpage>56</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a112356</pub-id><pub-id pub-id-type="pmid">401558</pub-id></mixed-citation></ref><ref id="R26"><label>26. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Garrido</surname><given-names>HMG</given-names></string-name>, <string-name name-style="western"><surname>Schnyder</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Tanck</surname><given-names>MWT</given-names></string-name>, <string-name name-style="western"><surname>Vollaard</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Spijker</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Grobusch</surname><given-names>MP</given-names></string-name>, <etal>et al.</etal><article-title>Immunogenicity of pneumococcal vaccination in HIV infected individuals: A systematic review and meta-analysis.</article-title><source>EClinicalMedicine</source>. <year>2020</year>;<volume>29-30</volume>:<elocation-id>100576</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2020.100576</pub-id><pub-id pub-id-type="pmid">33294820</pub-id><pub-id pub-id-type="pmcid">PMC7695973</pub-id></mixed-citation></ref><ref id="R27"><label>27. </label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Al-Soud</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>R&#229;dstr&#246;m</surname><given-names>P</given-names></string-name>. <article-title>Purification and characterization of PCR-inhibitory components in blood cells.</article-title><source>J Clin Microbiol</source>. <year>2001</year>;<volume>39</volume>:<fpage>485</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.39.2.485-493.2001</pub-id><pub-id pub-id-type="pmid">11158094</pub-id><pub-id pub-id-type="pmcid">PMC87763</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>